UPDATED Apr 19, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ULTI | kr8.31 | -16.6% | -93.6% | kr285.9m | kr6.50 | PB1x | E14.4% | n/a | ||
DMP | €31.90 | -4.8% | -30.4% | €1.7b | €57.90 | PE27.5x | E24.4% | 2.8% | ||
LIPUM | kr6.70 | -4.3% | -39.1% | kr62.4m | kr20.00 | PB13.7x | E74.9% | n/a | ||
BXPHARMA | ৳117.70 | -1.6% | -19.5% | ৳52.5b | ৳153.50 | PE10.7x | E15.0% | 3.0% | ||
IMUX | US$1.18 | -18.1% | -24.4% | US$106.1m | US$11.50 | PB3.7x | E57.8% | n/a | ||
ORGO | US$2.90 | 0.7% | 40.1% | US$382.7m | US$4.83 | PE77.4x | E59.4% | n/a | ||
MDXG | US$6.29 | -2.3% | 67.7% | US$924.4m | US$12.44 | PE16.6x | E15.0% | n/a | ||
FTRE | US$35.50 | -9.1% | n/a | US$3.2b | US$40.06 | PS1x | E46.6% | n/a | ||
PRGO | US$30.80 | 1.6% | -15.5% | US$4.2b | US$39.75 | PB0.9x | E45.7% | 3.6% |